NCT05574218

Brief Summary

This study was designed as a 12-month, two arms, randomized clinical trial to evaluate the efficacy of a supportive treatment protocol (SPIT). Thirty patients were randomized, six months after access-flap surgery, in two different SPIT groups. After ultrasonic debridement, the affected implant surfaces of the test group were treated with glycine powder air-polishing, while implants in the control group a rubber cup and polishing paste was used. Maintenance visits were carried every 3 months and clinical, radiological, microbiological and biochemical variables were registered at baseline (6 months after surgery) and after a follow-up period of 12 months (18 months after surgery).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 26, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 10, 2022

Completed
Last Updated

October 10, 2022

Status Verified

September 1, 2022

Enrollment Period

8.6 years

First QC Date

September 26, 2022

Last Update Submit

October 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Probing Pocket Depth

    Changes in Probing Pocket Depth measured in milimeters with a manual periodontal probe

    Baseline, 6 and 18 months after the surgical procedure

Secondary Outcomes (10)

  • Distance of Gingival Recession

    Baseline, 6 and 18 months after the surgical procedure

  • Bleeding on Probing index

    Baseline, 6 and 18 months after the surgical procedure

  • Plaque Index

    Baseline, 6 and 18 months after the surgical procedure

  • Suppuration Index

    Baseline, 6 and 18 months after the surgical procedure

  • Radiographic bone loss distance measured from the prosthetic connection platform to the bottom of the intraosseous defect

    Baseline, 6 and 18 months after the surgical procedure

  • +5 more secondary outcomes

Study Arms (2)

Glycine - Test

EXPERIMENTAL

Polishing treatment with glycine powder air-polishing after ultrasonic plaque debridement.

Procedure: Glycine air powder

Rubber cup - Control

ACTIVE COMPARATOR

Polishing treatment with a rubber cup and polishing paste after ultrasonic debridement

Procedure: Rubber cup polishing

Interventions

Every 3 months, ultrasonic instrumentation was carried out with an specific implant tip coated with Polyether Ether Ketone (PEEK), activated subgingivally and circumferentially around the implant. Then, the implants were treated with glycine powder air-polishing.

Glycine - Test

Every 3 months, ultrasonic instrumentation was carried out with an specific implant tip coated with Polyether Ether Ketone (PEEK), activated subgingivally and circumferentially around the implant. Then, the implants were treated with rubber cup and a polishing paste.

Rubber cup - Control

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of at least one implant with peri-implantitis, defined as: radiographic evidence of bone loss \>2 mm, inflammation of the peri-implant mucosa as defined by positive BoP and/or suppuration, and at least one site with PD ≥ 5 mm.
  • Based on the radiographic examination, the affected implant should not have a vertical peri-implant defect. Positive selection was based on the presence of pe-ri-implant lesions wider than 4 mm, with an angle greater than 35 º.
  • In patients with a history of periodontitis, periodontal therapy should have been provided at least 6 months prior to the initiation of the study.

You may not qualify if:

  • Presence of relevant medical conditions and/or systemic medications that would contraindicate the surgical procedure or modify the tissue response after therapy.
  • Patients requiring antibiotic prophylaxis.
  • Heavy smokers (\> 10 cigarettes/day).
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Clinical Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2022

First Posted

October 10, 2022

Study Start

January 1, 2013

Primary Completion

August 1, 2021

Study Completion

August 1, 2021

Last Updated

October 10, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share